PRO-PLATINUM: A randomized, double-blind, placebo controlled study to investigate the efficacy of a probiotic intervention on the gut and vaginal microbiome of ovarian cancer patients undergoing treatment with platinum chemotherapy.
Saved in:
| Title: | PRO-PLATINUM: A randomized, double-blind, placebo controlled study to investigate the efficacy of a probiotic intervention on the gut and vaginal microbiome of ovarian cancer patients undergoing treatment with platinum chemotherapy. |
|---|---|
| Authors: | Chambers LM; Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, USA. Electronic address: laura.chambers@osumc.edu., Spakowicz D; Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, USA., Chalif J; Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, USA., O'Connor R; Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, USA., Kistenfeger Q; Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, USA., Mehra Y; Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, USA; Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, USA., Mohssen M; Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, USA; Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, USA., Abdeen C; The Ohio State University School of Medicine, USA., Haight P; Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, USA., Nagel C; Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, USA., Neff R; Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, USA., Cohn D; Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, USA., Copeland LJ; Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, USA., Backes F; Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, USA., Cosgrove C; Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, USA., Hays J; Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, USA., Dravillas C; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., McLaughlin E; The Ohio State University School of Medicine, Department of Biostatistics, USA., O'Malley D; Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, USA. |
| Source: | Gynecologic oncology [Gynecol Oncol] 2026 Jun 27; Vol. 211, pp. 74-78. Date of Electronic Publication: 2026 Jun 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42364424 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: PRO-PLATINUM: A randomized, double-blind, placebo controlled study to investigate the efficacy of a probiotic intervention on the gut and vaginal microbiome of ovarian cancer patients undergoing treatment with platinum chemotherapy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Chambers+LM%22">Chambers LM</searchLink>; Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, USA. Electronic address: laura.chambers@osumc.edu.<br /><searchLink fieldCode="AU" term="%22Spakowicz+D%22">Spakowicz D</searchLink>; Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, USA.<br /><searchLink fieldCode="AU" term="%22Chalif+J%22">Chalif J</searchLink>; Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, USA.<br /><searchLink fieldCode="AU" term="%22O'Connor+R%22">O'Connor R</searchLink>; Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, USA.<br /><searchLink fieldCode="AU" term="%22Kistenfeger+Q%22">Kistenfeger Q</searchLink>; Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, USA.<br /><searchLink fieldCode="AU" term="%22Mehra+Y%22">Mehra Y</searchLink>; Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, USA; Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, USA.<br /><searchLink fieldCode="AU" term="%22Mohssen+M%22">Mohssen M</searchLink>; Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, USA; Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, USA.<br /><searchLink fieldCode="AU" term="%22Abdeen+C%22">Abdeen C</searchLink>; The Ohio State University School of Medicine, USA.<br /><searchLink fieldCode="AU" term="%22Haight+P%22">Haight P</searchLink>; Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, USA.<br /><searchLink fieldCode="AU" term="%22Nagel+C%22">Nagel C</searchLink>; Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, USA.<br /><searchLink fieldCode="AU" term="%22Neff+R%22">Neff R</searchLink>; Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, USA.<br /><searchLink fieldCode="AU" term="%22Cohn+D%22">Cohn D</searchLink>; Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, USA.<br /><searchLink fieldCode="AU" term="%22Copeland+LJ%22">Copeland LJ</searchLink>; Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, USA.<br /><searchLink fieldCode="AU" term="%22Backes+F%22">Backes F</searchLink>; Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, USA.<br /><searchLink fieldCode="AU" term="%22Cosgrove+C%22">Cosgrove C</searchLink>; Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, USA.<br /><searchLink fieldCode="AU" term="%22Hays+J%22">Hays J</searchLink>; Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, USA.<br /><searchLink fieldCode="AU" term="%22Dravillas+C%22">Dravillas C</searchLink>; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.<br /><searchLink fieldCode="AU" term="%22McLaughlin+E%22">McLaughlin E</searchLink>; The Ohio State University School of Medicine, Department of Biostatistics, USA.<br /><searchLink fieldCode="AU" term="%22O'Malley+D%22">O'Malley D</searchLink>; Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220365304%22">Gynecologic oncology</searchLink> [Gynecol Oncol] 2026 Jun 27; Vol. 211, pp. 74-78. <i>Date of Electronic Publication: </i>2026 Jun 27. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Academic+Press%22">Academic Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0365304 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1095-6859 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200908258%22">00908258 </searchLink><i>NLM ISO Abbreviation: </i>Gynecol Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42364424 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ygyno.2026.06.016 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 74 Titles: – TitleFull: PRO-PLATINUM: A randomized, double-blind, placebo controlled study to investigate the efficacy of a probiotic intervention on the gut and vaginal microbiome of ovarian cancer patients undergoing treatment with platinum chemotherapy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Chambers LM – PersonEntity: Name: NameFull: Spakowicz D – PersonEntity: Name: NameFull: Chalif J – PersonEntity: Name: NameFull: O'Connor R – PersonEntity: Name: NameFull: Kistenfeger Q – PersonEntity: Name: NameFull: Mehra Y – PersonEntity: Name: NameFull: Mohssen M – PersonEntity: Name: NameFull: Abdeen C – PersonEntity: Name: NameFull: Haight P – PersonEntity: Name: NameFull: Nagel C – PersonEntity: Name: NameFull: Neff R – PersonEntity: Name: NameFull: Cohn D – PersonEntity: Name: NameFull: Copeland LJ – PersonEntity: Name: NameFull: Backes F – PersonEntity: Name: NameFull: Cosgrove C – PersonEntity: Name: NameFull: Hays J – PersonEntity: Name: NameFull: Dravillas C – PersonEntity: Name: NameFull: McLaughlin E – PersonEntity: Name: NameFull: O'Malley D IsPartOfRelationships: – BibEntity: Dates: – D: 27 M: 06 Text: 2026 Jun 27 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1095-6859 Numbering: – Type: volume Value: 211 Titles: – TitleFull: Gynecologic oncology Type: main |
| ResultId | 1 |
